investor.insmed.comInvestor Relations | Insmed Incorporated

Close Skip to main content Skip to footer Insmed My WordPress Blog MENU / Investors / Investor Relations Investor Relations Insmed (Nasdaq:INSM) is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Our strong and experienced management team embodies our culture, setting the tone for an organization that acts boldly, thinks creatively, and puts patients first in everything we do. Explore the Investor Center to learn more about our company. Download the Investor Presentation In this section Select page... Investor Relations Events & Presentations Stock Information News Releases SEC Filings Annual Reports Analyst Coverage Corporate Governance Email Alerts Investor FAQs As a champion for the rare disease community, we are dedicated to supporting patients and their families along their journey. Latest News Email Alerts May 10, 2021 Insmed Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2028 BRIDGEWATER, N.J., May 10, 2021 /PRNewswire/ — Insmed Incorporated (Nasdaq: INSM) announced today that it intends to offer and sell $250 million of its common stock (the "Shares") and $500... May 7, 2021 Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement... View All Events & Presentations Insmed First Quarter 2021 Financial Results Thursday, May 6, 2021 8:30am - 9:30am EDT H.C. Wainwright Global Life Sciences Conference Tuesday, March 9, 2021 7:00am EST View All -- Stock Performance Summary Stock Performance Summary NASDAQ INSM 2020 Annual Report & Proxy Statement 2020 Annual Report Visit our Annual Report landing page Download 2020 Annual Report Download 2021 Proxy Statement Tools and Resources Stay in the loop Want to stay up to date on our news, events, and filings? Set up your email alerts. Sign Up Investor Presentation View the latest Insmed Investor Presentation here. Download Investor & Media Contacts Investors Eleanor Barisser Associate Director, Investor Relations, Insmed (718) 594-5332 Email Media Mandy Fahey Senior Director, Corporate Communications, Insmed (732) 487-7468 Email Footer Culture Mission & Vision Careers Responsibility Patients ARIKAYCE ® PULMOVANCE ® Liposomal Technology Resources Science Our Research Team Pipeline and Diseases Clinical Trials Investigator-Initiated Research About History Management Team Board of Directors Global Healthcare Compliance Partnerships Investors Events & Presentations Stock Information News Releases SEC Filings Annual Reports Analyst Coverage Corporate Governance Email Alerts Investor FAQs Follow Us Contact Us © Insmed 2019. All Rights Reserved. Terms of Use Privacy Policy -- Contact Us Insmed Incorporated © 2021 All rights reserved. Insmed Incorporated © 2021 All rights reserved. Insmed, ARIKAYCE, Arikares, and PULMOVANCE are trademarks of Insmed Incorporated. All other trademarks are property of their respective owner. Terms of Use Privacy Policy Contact Us Culture Mission & Vision Careers Responsibility Patients ARIKAYCE ® PULMOVANCE ® Liposomal Technology Resources Science Our Research Team Pipeline and Diseases Clinical Trials Investigator-Initiated Research About History Management Team Board of Directors Global Healthcare Compliance Partnerships Investors Investor Relations Events & Presentations Stock Information News Releases SEC Filings Annual Reports Analyst Coverage Corporate Governance Email Alerts Investor FAQs Contact Us © Insmed 2021 All Rights Reserved. Terms of Use Privacy Policy Effective January 1, 2020, we have modified our Privacy Policy . Please read these updated terms and take some time to understand them. This website, as well as certain third parties that provide content, other functionality, or services to this site, may use Internet technologies to collect information. These technologies include cookies, local stored objects, web beacons, and other means. By using this site, you consent to our use of such cookies and similar technologies . Ok...